Erschienen in:
29.04.2022 | Concise Research Report
Patient and Clinician Characteristics Associated with Use of Telemedicine for Buprenorphine Induction Among Medicare Beneficiaries
verfasst von:
Sadiq Y. Patel, PhD MS MSW, Esteban G. Ortiz, BS, Benjamin A. Barsky, JD, Haiden A. Huskamp, PhD, Alisa B. Busch, MD MS, Ateev Mehrotra, MD MPH
Erschienen in:
Journal of General Internal Medicine
|
Ausgabe 14/2022
Einloggen, um Zugang zu erhalten
Excerpt
The 2008 Ryan Haight Act generally requires an in-person medical evaluation before the prescribing of medications such as buprenorphine for opioid use disorder (MOUD).
1,2 Early in the COVID-19 pandemic (March 2020), the requirement was temporarily waived
3 and there was a sharp increase in MOUD inductions via telemedicine.
4 …